DaVita Clinical Research (DCR), a provider of clinical research services focused on kidney research, has hired four individuals to ignite the expansion of DCR at its latest clinical research facility in Denver, Colo. The new team members include: Dr. Christopher Galloway, medical director; Chad Jaeger, senior director of clinical operations; Amy Denvir, director of operations-Denver; and Michael Kreuter, director of data management.
Galloway brings to DCR more than 12 years of medical practice, including six years within emergency and critical care. Before accepting the medical director position at DCR, he served as an attending physician for Capitol Emergency Associates in Austin, Texas, Front Range Emergency Associates in Colorado Springs, Colo., and the University of Tennessee in Knoxville.
Jaeger’s involvement within the early clinical research industry spans the past 16 years in both clinical and commercial operations and includes former employers Harris Laboratories, MDS Pharma Services and Radiant Research. His last position prior to joining DCR as senior director of clinical operations, was senior account executive for Covance’s early clinical pharmacology units. Jaeger is also a member of the American Society for Clinical Pharmacology and Therapeutics (ASCPT).
As the director of operations-Denver, Denvir will utilize more than 20 years of early phase CRO industry experience to successfully launch the new Denver facility and ensure good clinical practice (GCP) is maintained. Denvir formerly worked for Metroplex Clinical Research Center, Covance, Radiant Research and MDS Pharma Services in a variety of operational leadership roles.
Before joining DCR as director of data management, Kreuter held various senior level data management positions, spanning 16 years, at several organizations: Sanofi Pasteur, M3 Clinical Research and SDI.